Client focused,
powered by data

We are committed to providing high quality real world evidence in collaboration with our stakeholders to improve health outcomes in real-world settings.

kaolel photo 8
kaolel photo 5

Kaolel is a California based company focused solely on the life science industry.

We are deeply embedded in real world evidence generation at all stages of development and commercialization of drugs and medical devices. Our core strength as an evidence-based platform is our unmatched solutions in characterizing real-world use, and clinical and economic value of medical products and devices.

We are a proven partner with solid knowledge in epidemiology methods, biostatistical analysis, data science and health economics. We work with our clients to lighten the burden of proof and communicate the real-world value of their medical product to meet the needs of their stakeholders.

We invite you to leverage our platform to accelerate product time to market, reduce development costs, and innovate with the power of real world data and artificial intelligence to stay ahead of the curve.

Who we partner & collaborate with

Kaolel offers a full range of real-world evidence services in strategy, consulting, study execution and technology that help deliver the best outcomes for patients. We work with stakeholders in Pharmaceutical, Biotechnology and medical device companies across the globe. 

Research & Development

Research and Development (R&D) in the industry has traditionally relied on controlled, randomized clinical trials (RCTs) to gather evidence for the safety and efficacy of new interventions. While RCTs are the gold standard for establishing causality and ensuring that new drugs or interventions are safe and effective, they have limitations in terms of generalizability and capturing the complexity of real-world scenarios. Real World Evidence (RWE) offers a complementary approach by using data from real-world settings, such as:
  • Electronic health records
  • Insurance claims
  • Patient registries
  • And more

    • Here's how Kaolel leverages RWE to support and rive your R&D strategy.

Medical Affairs

Medical Affairs is a strategic function within life science companies, responsible for the generation and communication of scientific and clinical data to a variety of stakeholders, including healthcare providers. With the increasing relevance of Real-World Evidence (RWE) in the healthcare ecosystem, Medical Affairs teams are poised to play an essential role in leveraging and communicating these insights. Here's how Kaolel can leverage RWE to support and drive the Medical Affairs evidence strategy.

Commercial and Market Access

Regulatory approval of new drug or medical device—that’s only half the battle. Getting the heath technology to the patient to improve health is the next hurdle. It involves navigating complex systems of health technology assessment (HTA), pricing, and reimbursement. Real-World Evidence (RWE) is becoming an increasingly influential tool in market access strategies. Here's how Kaolel can leverage RWE to support and drive your market access strategy.

RWE and HEOR Teams

Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) are integral parts of the life sciences industry. These teams focus on understanding the characteristics, value, effectiveness, and safety of treatments in real-world settings. Here's how Kaolel can leverage RWE to support and drive RWE and HEOR Teams strategy.

Meet our executive leadership team


Rhonda McWilliam

Head of Business Operations

Rhonda has a Masters in Business Administration and extensive experience in the healthcare industry, specializing in business development, project management and physician relations. She has a broad knowledge of health administration, serving as both a director of surgery administration in the public sector and a medical services administrator in the military. In her role with Kaolel, Rhonda will oversee a broad range of business operations, including internal office procedures, business development and logistics management. Outside of work, Rhonda enjoys traveling, hiking with the family dog, and spending time with her husband and daughters.


Carrie Green

Director of Business Development

Carrie holds a Bachelor of Arts in English and Journalism & Mass Media from Rutgers University. She has over 15 years of experience in the pharmaceutical industry with one of the world’s largest pharmaceutical companies, where she led numerous sales teams. For the last 13 years, Carrie spearheaded marketing, new business development, and workforce optimization solutions for a leadership development firm, helping numerous pharmaceutical and biotech organizations develop leaders to their fullest potential. As Director of Business Development with Kaolel, Carrie will develop marketing strategies and oversee our client outreach efforts. In her free time, she enjoys spending time with her husband and three children, walking the family dog, learning new things, and listening to audible books.


Lakmini Bulathsinhala

Head RWE and HEOR

Lakmini is a masters graduate of Epidemiology from George Washington University. She has led research projects in observational and experimental epidemiology for twelve years in both the public and private sector. She has produced over 25 scientific publications in peer reviewed journals. Lakmini will lead Kaolel’s evidence generation strategy and execution. During her free time, she enjoys hiking, playing tennis, practicing yoga and spending time with family.